Article Sidebar
Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
A preliminary review of the uses of chlorpromazine in psychiatric diseases
Abstract
Amongst the recent advances in psychiatric treatmentby means of drugs, chlorpromazine is playing an ever increasing and important role. It was first used clinically by Laborit and Hugenard in 1951 in relation to anaesthetics and' later (1953) by ,Delay and Denikerl in psychiatry. It has been adopted generally for virtually every known psychiatric illness and varying opinions have been expressed concerning its efficacy. At the Oranje Hospital it has been in active use for the past 8 months with varying-sometimes startling-results. It has been tried alone or in combination with other drugs or electroconvulsive therapy (etc.).
